Onivyde (Merrimack Pharmaceuticals)
Welcome to the PulseAid listing for the Onivyde drug offered from Merrimack Pharmaceuticals. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merrimack Pharmaceuticals |
| NON-PROPRIETARY NAME: | Irinotecan hydrochloride |
| SUBSTANCE NAME: | IRINOTECAN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-10-22 |
| END MARKETING DATE: | 0000-00-00 |
Onivyde HUMAN PRESCRIPTION DRUG Details:
| Item Description | Onivyde from Merrimack Pharmaceuticals |
| LABELER NAME: | Merrimack Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4.3(mg/mL) |
| START MARKETING DATE: | 2015-10-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69171-398_2be9f49d-e7c2-4846-e054-00144ff8d46c |
| PRODUCT NDC: | 69171-398 |
| APPLICATION NUMBER: | NDA207793 |
Other IRINOTECAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
